Department of Surgery, Kuma Hospital, Kobe, Hyogo 650-0011, Japan.
Department of Diagnostic Pathology and Cytology, Kuma Hospital, Kobe, Hyogo 650-0011, Japan.
Endocr J. 2021 Aug 28;68(8):881-888. doi: 10.1507/endocrj.EJ21-0064. Epub 2021 Mar 20.
Widely invasive follicular thyroid carcinoma (wi-FTC) is regarded as having an aggressive character and a dire prognosis, but it has not been known whether all wi-FTCs have a dire prognosis. Herein we retrospectively analyzed the cases of 133 patients with wi-FTCs to determine the prognostic significance of vascular invasion and cell-proliferation activity based on the Ki-67 labeling index (LI). Of the 119 patients without distant metastasis (M0), 11 (9.2%) showed recurrence during the postoperative follow-up. In a univariate analysis, the recurrence-free survival (RFS) rates of the M0 patients with vascular invasion and those with a Ki-67 LI ≥5% were significantly poorer (p = 0.0013 and p = 0.0268, respectively) than those of the patients without vascular invasion or with a Ki-67 LI <5%. Other clinicopathological factors such as patient age, gender, tumor size, and oxyphilic tumor were not significantly related to the patients' RFS. In a multivariate analysis, positive vascular invasion independently affected the RFS (p = 0.0133), but Ki-67 >5% did not (p = 0.1348). To date, only five patients have died of their thyroid carcinoma; four cases were M1. In conclusion, although M0 wi-FTC generally has a favorable prognosis, cases with positive vascular invasion or a high Ki-67 LI are likely to recur, and careful postoperative follow-up is necessary.
广泛浸润性滤泡状甲状腺癌(wi-FTC)被认为具有侵袭性和不良预后,但并非所有 wi-FTC 都具有不良预后。本研究回顾性分析了 133 例 wi-FTC 患者的病例,以确定基于 Ki-67 标记指数(LI)的血管侵犯和细胞增殖活性的预后意义。在 119 例无远处转移(M0)的患者中,有 11 例(9.2%)在术后随访期间复发。单因素分析显示,M0 患者中存在血管侵犯和 Ki-67 LI≥5%的患者,其无复发生存率(RFS)显著较差(p=0.0013 和 p=0.0268),明显低于无血管侵犯或 Ki-67 LI<5%的患者。其他临床病理因素,如患者年龄、性别、肿瘤大小和嗜酸性肿瘤与患者的 RFS 无显著相关性。多因素分析显示,阳性血管侵犯独立影响 RFS(p=0.0133),而 Ki-67>5%则没有(p=0.1348)。迄今为止,仅有 5 例患者死于甲状腺癌,其中 4 例为 M1。综上所述,尽管 M0 wi-FTC 通常具有良好的预后,但存在阳性血管侵犯或 Ki-67 LI 较高的病例可能会复发,因此需要进行仔细的术后随访。